Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.295
+0.007 (2.25%)
At close: Mar 9, 2026, 4:00 PM EDT
0.294
-0.001 (-0.44%)
After-hours: Mar 9, 2026, 7:26 PM EDT

Plus Therapeutics Revenue

Plus Therapeutics had revenue of $1.40M in the quarter ending September 30, 2025, a decrease of -4.05%. This brings the company's revenue in the last twelve months to $5.26M, down -8.16% year-over-year. In the year 2024, Plus Therapeutics had annual revenue of $5.82M with 18.54% growth.

Revenue (ttm)
$5.26M
Revenue Growth
-8.16%
P/S Ratio
9.71
Revenue / Employee
$250,381
Employees
21
Market Cap
52.22M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20245.82M911.00K18.54%
Dec 31, 20234.91M4.69M2,093.30%
Dec 31, 2022224.00K--
Dec 31, 2021---
Dec 31, 2020303.00K-6.70M-95.67%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro